Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-22 to 2023-09-25
Current total value of award: $4580.49
Description: 4562278007!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML